Breast Cancer Research and Treatment

, Volume 123, Supplement 1, pp 55–58 | Cite as

Breast cancer during pregnancy

  • Mª Concepción Sánchez Martínez
  • Amparo Ruiz Simón
Brief Report


  1. 1.
    Ring AE, Smith IE, Ellis PA (2005) Breast cancer and pregnancy. Ann Oncol 16(12):1855–1860CrossRefPubMedGoogle Scholar
  2. 2.
    Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279–287PubMedGoogle Scholar
  3. 3.
    Anderson JM (1979) Mammary cancers and pregnancy. Br Med J 1(6171):1124–1127CrossRefPubMedGoogle Scholar
  4. 4.
    Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B et al (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237–246CrossRefPubMedGoogle Scholar
  5. 5.
    Gentilini O, Masullo M, Rotmensz N, Peccatori F, Mazzarol G, Smeets A et al (2005) Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur J Surg Oncol 31(3):232–236CrossRefPubMedGoogle Scholar
  6. 6.
    Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A (2003) Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 98(5):1055–1060CrossRefPubMedGoogle Scholar
  7. 7.
    Euler U, Knopf B, Tulusan AH (2004) Breast cancer in young women aged 35 or less. ASCO Meet Abstr 22(14_suppl):754Google Scholar
  8. 8.
    Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138(1):91–98 discussion 99CrossRefPubMedGoogle Scholar
  9. 9.
    (2008) Protocolo de cáncer de mama y embarazo. Accessed November 2008
  10. 10.
    Gwyn KM, Theriault RL (2000) Breast cancer during pregnancy. Curr Treat Options Oncol 1(3):239–243CrossRefPubMedGoogle Scholar
  11. 11.
    Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS et al (2007) Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103(1):93–102CrossRefPubMedGoogle Scholar
  12. 12.
    Clark RM, Chua T (1989) Breast cancer and pregnancy: the ultimate challenge. Clin Oncol (R Coll Radiol) 1(1):11–18Google Scholar
  13. 13.
    Kuerer HM, Gwyn K, Ames FC, Theriault RL (2002) Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131(1):108–110CrossRefPubMedGoogle Scholar
  14. 14.
    Amersi F, Hansen NM (2006) The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol 7(2):141–151CrossRefPubMedGoogle Scholar
  15. 15.
    Wiebe VJ, Sipila PE (1994) Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 16(2):75–112CrossRefPubMedGoogle Scholar
  16. 16.
    Doll DC, Ringenberg QS, Yarbro JW (1989) Antineoplastic agents and pregnancy. Semin Oncol 16(5):337–346PubMedGoogle Scholar
  17. 17.
    Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE et al (2002) Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 194(1):54–64CrossRefPubMedGoogle Scholar
  18. 18.
    Kerr JR (2005) Neonatal effects of breast cancer chemotherapy administered during pregnancy. Pharmacotherapy 25(3):438–441CrossRefPubMedGoogle Scholar
  19. 19.
    Giacalone PL, Laffargue F, Benos P (1999) Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 86(11):2266–2272CrossRefPubMedGoogle Scholar
  20. 20.
    Aviles A, Niz J (1988) Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 16(1):3–6CrossRefPubMedGoogle Scholar
  21. 21.
    Azim HA Jr, Peccatori FA, Scarfone G, Acaia B, Rossi P, Cascio R et al (2008) Anthracyclines for gestational breast cancer: course and outcome of pregnancy. Ann Oncol 19(8):1511–1512CrossRefPubMedGoogle Scholar
  22. 22.
    Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM et al (2008) Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 19(4):607–613CrossRefPubMedGoogle Scholar
  23. 23.
    Sekar R, Stone PR (2007) Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol 110(2 Pt 2):507–510PubMedGoogle Scholar
  24. 24.
    Marty M, Mignot L, Gisselbrecht G, Morvan F, Gorins A, Boiron M (1985) Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception. Contracept Fertil Sex (Paris) 13(1 Suppl):181–186Google Scholar
  25. 25.
    Fenig E, Mishaeli M, Kalish Y, Lishner M (2001) Pregnancy and radiation. Cancer Treat Rev 27(1):1–7CrossRefPubMedGoogle Scholar
  26. 26.
    Isaacs RJ, Hunter W, Clark K (2001) Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review. Gynecol Oncol 80(3):405–408CrossRefPubMedGoogle Scholar
  27. 27.
    Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C et al (2005) Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 117(6):988–991CrossRefPubMedGoogle Scholar
  28. 28.
    Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H et al (2003) BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res 5(5):R121–R128CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Mª Concepción Sánchez Martínez
    • 1
  • Amparo Ruiz Simón
    • 2
  1. 1.Ginecology Service, Breast Pathology UnitHospital Universitario Ramón y CajalMadridSpain
  2. 2.Medical Oncology DepartmentInstituto Valenciano de OncologíaValenciaSpain

Personalised recommendations